115 results
8-K
EX-99.1
BLFS
Biolife Solutions Inc
31 Aug 23
Regulation FD Disclosure
5:15pm
Accolades 20202015 2022
BioLife Solutions Investor Presentation : August 202317 Regenerative Medicine Market
BioLife Solutions Investor Presentation … : August 202318 Active Regenerative Medicine Clinical Trials Cell therapies: 46% Cell-based immuno-oncology (CBIO): 34% Gene therapies: 18% Tissue
S-8
311nzloz8mtqy5
12 Sep 22
Registration of securities for employees
5:16pm
8-K
wsm8ri8b77d84h ueo
7 Oct 21
Departure of Directors or Certain Officers
7:30am
S-3ASR
syxdos
1 Sep 21
Automatic shelf registration
5:01pm
S-8
joxh4oak
7 Jul 21
Registration of securities for employees
5:19pm